Complete Filing Data
OneMedNet Corp reported Stockholders Equity of -$2.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean OneMedNet Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$2.8M | -$10.1M | -$33.8M | -$6.2M | $5.1M |
| Operating Income Loss | -$9.7M | -$9.6M | -$6.9M | -$11.4M | -$585.4K |
| Nonoperating Income Expense | $6.9M | -$522.0K | -$26.9M | $5.2M | -$625.1K |
| Selling And Marketing Expense | $1.3M | $830.0K | $1.1M | $957.7K | |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.4M | $643.0K | $1.0M | $1.2M | |
| Research And Development Expense | $1.5M | $1.5M | $2.1M | $952.7K | |
| Operating Expenses | $9.2M | $9.3M | $6.7M | $11.1M | |
| Gross Profit | -$503.0K | -$281.0K | -$129.0K | -$360.7K | |
| General And Administrative Expense | $6.4M | $7.0M | $3.5M | $8.8M | |
| Cost Of Revenue | $1.9M | $924.0K | $1.2M | $1.5M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.8M | -$10.1M | -$33.8M | $551.5K | $5.1M |
| Deferred Revenue Current | $389.0K | $561.0K | $254.0K | $183.7K | |
| Other Nonoperating Income Expense | -$16.0K | -$60.0K | -$34.0K | ||
| Income Tax Expense Benefit | $1.0K | $2.0K | $18.0K | $214.9K | |
| Interest Expense Nonoperating | $67.0K | $147.0K | $11.0K | ||
| Accrual For Taxes Other Than Income Taxes Current | $70.0K | $164.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$741.0K | $3.0M | -$1.9M | -$2.1M | -$3.6M | -$2.1M | -$13.8M | -$9.6M | -$7.8M | -$153.3K | $949.9K | $2.2M | $1.3M | $4.3M | -$845.00 |
| Operating Income Loss | -$2.2M | -$2.1M | -$2.2M | -$2.3M | -$2.5M | -$2.1M | -$1.9M | -$1.6M | -$1.5M | -$520.0K | -$794.5K | -$610.2K | -$98.7K | -$70.5K | -$845.00 |
| Nonoperating Income Expense | $1.5M | $5.0M | $322.0K | $278.0K | -$1.1M | -$8.0K | -$11.9M | -$8.0M | -$6.4M | $0.00 | -$625.1K | ||||
| Selling And Marketing Expense | $304.0K | $257.0K | $290.0K | $140.0K | $253.0K | $229.0K | $243.0K | $311.0K | $259.0K | ||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $177.0K | $155.0K | $137.0K | $142.0K | $227.0K | $248.0K | $326.0K | $173.0K | $200.0K | ||||||
| Research And Development Expense | $323.0K | $382.0K | $348.0K | $298.0K | $383.0K | $445.0K | $405.0K | $579.0K | $582.0K | ||||||
| Operating Expenses | $2.0M | $1.8M | $2.0M | $2.3M | $2.4M | $2.0M | $2.0M | $1.5M | $1.4M | ||||||
| Gross Profit | -$222.0K | -$241.0K | -$224.0K | -$84.0K | -$102.0K | -$69.0K | $33.0K | -$57.0K | -$89.0K | ||||||
| General And Administrative Expense | $1.4M | $1.2M | $1.4M | $1.8M | $1.7M | $1.4M | $1.3M | $624.0K | $539.0K | ||||||
| Cost Of Revenue | $399.0K | $396.0K | $361.0K | $226.0K | $329.0K | $317.0K | $293.0K | $230.0K | $289.0K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $57.5K | -$26.4K | -$46.6K | $949.9K | $2.2M | $1.3M | |||||||||
| Deferred Revenue Current | $770.0K | $512.0K | $503.0K | $428.0K | $519.0K | $456.0K | $393.8K | ||||||||
| Other Nonoperating Income Expense | -$8.0K | -$12.0K | -$4.0K | -$20.0K | $7.0K | -$7.0K | -$29.0K | -$8.0K | |||||||
| Income Tax Expense Benefit | $62.7K | $59.6K | $106.7K | ||||||||||||
| Interest Expense Nonoperating | $6.0K | $22.0K | $31.0K | $36.0K | $41.0K | $42.0K | |||||||||
| Accrual For Taxes Other Than Income Taxes Current | $8.0K | $117.4K | $50.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$3.0M | -$16.0M | -$13.4M | -$26.4M | $14.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $413.0K | $125.0K | -$224.0K | -$850.7K | $453.2K |
| Retained Earnings Accumulated Deficit | -$104.4M | -$101.6M | -$91.4M | -$43.5M | -$8.6M |
| Liabilities And Stockholders Equity | $2.2M | $3.7M | $464.0K | $30.4M | $117.9M |
| Assets | $2.2M | $3.7M | $464.0K | $30.4M | $117.9M |
| Liabilities | $5.1M | $19.7M | $13.9M | $21.2M | $9.2M |
| Liabilities Current | $4.8M | $19.2M | $13.8M | $11.8M | $290.0K |
| Assets Current | $2.1M | $3.6M | $365.0K | $30.4M | $536.2K |
| Cash And Cash Equivalents At Carrying Value | $585.0K | $172.0K | $47.0K | $301.7K | $453.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $585.0K | $172.0K | $47.0K | $271.0K | $1.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | ||||
| Warrant Liability Non Current | $71.0K | $15.0K | $24.6K | $362.6K | $4.9M |
| Common Stock Subject To Possible Redemption Value | -$28.8M | -$3.4M | $19.1M | ||
| Increase Decrease Franchise Tax Payable | -$70.0K | -$94.0K | $164.0K | ||
| Property Plant And Equipment Net | $56.0K | $108.0K | $99.0K | $83.1K | |
| Prepaid Expense And Other Assets Current | $509.0K | $385.0K | $166.0K | $100.9K | |
| Accounts Receivable Net Current | $495.0K | $213.0K | $152.0K | $19.0K | |
| Accounts Payable And Accrued Liabilities Current | $3.5M | $6.0M | $4.7M | $2.8M | |
| Common Stock Value | $2.0K | $2.0K | $2.0K | $455.00 | |
| Assets Held In Trust Noncurrent | $117.3M | ||||
| Deferred Offering Costs Non Current | $4.0M | ||||
| Other Liabilities Noncurrent | $68.0K | ||||
| Accrued Liabilities Excluding Offering Costs Current | $126.0K | ||||
| Fair Value Adjustment Of Private Investment In Public Equity | $97.0K | $269.0K | |||
| Deferred Underwriter Fee Payable Current | $3.3M | $3.5M | |||
| Treasury Stock Common Shares | 187.7K | 187.7K | 0.00 | ||
| Temporary Equity Carrying Amount Attributable To Parent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$3.9M | -$3.8M | -$16.6M | -$14.3M | -$19.2M | -$15.7M | -$47.8M | -$39.1M | -$31.9M | -$8.5M | -$6.6M | -$6.4M | -$8.1M | -$9.4M | $24.2K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$28.0K | $127.0K | -$126.0K | -$294.0K | $25.0K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$101.2M | -$100.5M | -$103.5M | -$99.2M | -$97.1M | -$93.5M | -$36.8M | -$11.7M | -$11.7M | -$8.5M | -$6.6M | -$6.4M | -$8.1M | -$9.4M | ||||
| Liabilities And Stockholders Equity | $1.5M | $2.3M | $1.7M | $4.4M | $1.0M | $750.0K | $2.9M | $30.0M | $29.7M | $120.4M | $118.7M | $117.6M | $118.0M | $118.1M | ||||
| Assets | $1.5M | $2.3M | $1.7M | $4.4M | $1.0M | $750.0K | $2.9M | $30.0M | $29.7M | $120.4M | $118.7M | $117.6M | $118.0M | $118.1M | ||||
| Liabilities | $5.4M | $6.2M | $18.3M | $18.7M | $20.2M | $16.5M | $17.7M | $10.1M | $9.9M | $8.7M | $6.8M | $6.7M | $8.8M | $10.3M | ||||
| Liabilities Current | $5.0M | $6.2M | $18.2M | $18.6M | $20.0M | $14.7M | $14.3M | $2.1M | $2.3M | $1.5M | $1.2M | $566.4K | $16.1K | $51.8K | ||||
| Assets Current | $1.4M | $2.3M | $1.6M | $4.3M | $956.0K | $656.0K | $2.8M | $3.4K | $10.1K | $234.9K | $7.5K | $202.5K | $677.7K | $812.1K | ||||
| Cash And Cash Equivalents At Carrying Value | $149.0K | $122.0K | $144.0K | $1.9M | $407.0K | $174.0K | $611.8K | $3.4K | $10.1K | $234.9K | $7.5K | $159.1K | $533.7K | $802.1K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $149.0K | $122.0K | $144.0K | $1.9M | $707.0K | $174.0K | $612.0K | $312.0K | $145.0K | $312.3K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.4K | $10.1K | $30.9K | $234.9K | $7.5K | $159.1K | $453.2K | $533.7K | $802.1K | $25.0K | ||||||||
| Warrant Liability Non Current | $362.6K | $362.6K | $607.8K | $493.9K | $2.1M | $4.8M | $6.2M | |||||||||||
| Common Stock Subject To Possible Redemption Value | $604.7K | $583.6K | $1.2M | $1.2M | $117.3M | |||||||||||||
| Increase Decrease Franchise Tax Payable | $47.5K | -$114.0K | $0.00 | |||||||||||||||
| Property Plant And Equipment Net | $60.0K | $70.0K | $101.0K | $84.0K | $85.0K | $94.0K | $92.4K | |||||||||||
| Prepaid Expense And Other Assets Current | $115.0K | $293.0K | $447.0K | $151.0K | $174.0K | $229.0K | $87.4K | |||||||||||
| Accounts Receivable Net Current | $582.0K | $254.0K | $247.0K | $63.0K | $75.0K | $253.0K | $86.4K | |||||||||||
| Accounts Payable And Accrued Liabilities Current | $3.8M | $5.2M | $6.9M | $6.2M | $6.5M | $5.9M | $1.5M | |||||||||||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $455.00 | |||||||||||
| Assets Held In Trust Noncurrent | $30.0M | $29.7M | $29.0M | $120.1M | $118.7M | $117.4M | $117.3M | $117.3M | ||||||||||
| Deferred Offering Costs Non Current | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | |||||||||||
| Other Liabilities Noncurrent | $440.0K | $18.0K | $128.0K | $449.0K | $28.0K | $22.0K | $16.0K | $3.3M | $207.1K | |||||||||
| Accrued Liabilities Excluding Offering Costs Current | $2.0M | $1.9M | $1.7M | $1.3M | $1.1M | $516.4K | $16.1K | $51.8K | ||||||||||
| Fair Value Adjustment Of Private Investment In Public Equity | -$1.1M | -$133.0K | -$77.0K | $52.0K | -$20.0K | |||||||||||||
| Deferred Underwriter Fee Payable Current | $3.3M | $3.2M | $3.3M | $3.3M | ||||||||||||||
| Treasury Stock Common Shares | 187.7K | 187.7K | 187.7K | 187.7K | 187.7K | 187.7K | ||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $118.5M | $117.3M | $117.3M | $117.3M | $117.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.5M | -$7.0M | -$4.8M | $87.2M | -$378.5K |
| Net Cash Provided By Used In Financing Activities | $5.6M | $9.1M | $4.6M | -$88.0M | $118.1M |
| Net Cash Provided By Used In Investing Activities | $2.3M | -$2.0M | -$44.0K | -$2.2M | -$117.3M |
| Payments For Investment Of Cash In Trust Account | $2.5M | $117.3M | |||
| Share Based Compensation | $2.0M | $628.0K | $1.5M | $1.6M | $0.00 |
| Increase Decrease In Accounts Receivable | $282.0K | $61.0K | $133.0K | -$72.8K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $366.0K | $1.2M | $717.0K | $1.9M | |
| Depreciation Depletion And Amortization | $65.0K | $57.0K | $28.0K | $24.8K | |
| Payments To Acquire Property Plant And Equipment | $13.0K | $51.0K | $44.0K | $58.1K | |
| Increase Decrease In Accrued Liabilities | $1.6M | $126.0K | |||
| Increase Decrease In Prepaid Expense | $64.6K | -$83.1K | $83.1K | ||
| Increase Decrease In Deferred Revenue | -$172.0K | $307.0K | $70.0K | ||
| Increase Decrease In Prepaid Expenses Other | -$194.0K | -$84.0K | $43.0K | ||
| Proceeds From Convertible Debt | $4.5M | $4.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.9M | -$1.5M | -$1.0M | -$294.0K | $0.00 | ||
| Net Cash Provided By Used In Financing Activities | $1.7M | $876.0K | $25.0K | ||||
| Net Cash Provided By Used In Investing Activities | $1.9M | -$6.0K | -$368.8K | ||||
| Payments For Investment Of Cash In Trust Account | $122.9K | $368.8K | $117.3M | ||||
| Share Based Compensation | $208.0K | $137.0K | $368.0K | ||||
| Increase Decrease In Accounts Receivable | $34.0K | $101.0K | $235.0K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $216.0K | $380.0K | $271.0K | ||||
| Depreciation Depletion And Amortization | $12.0K | $11.0K | $6.0K | ||||
| Payments To Acquire Property Plant And Equipment | $5.0K | $6.0K | |||||
| Increase Decrease In Accrued Liabilities | $253.8K | $390.4K | $845.00 | ||||
| Increase Decrease In Prepaid Expense | -$39.7K | $0.00 | |||||
| Increase Decrease In Deferred Revenue | -$58.0K | $202.0K | $91.0K | ||||
| Increase Decrease In Prepaid Expenses Other | $62.0K | $63.0K | $26.0K | ||||
| Proceeds From Convertible Debt | $1.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.06 | -$0.36 | -$4.65 | $0.03 | $0.44 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 44.5M | 28.1M | 7.3M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 44.5M | 28.1M | 7.3M | ||
| Earnings Per Share Basic | $-0.06 | $-0.36 | $-4.65 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 52.0M | 28.0M | 23.6M | 4.6M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 30.0M | |
| Common Stock Shares Issued | 52.2M | 28.2M | 23.6M | 4.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | $0.07 | -$0.06 | -$0.07 | -$0.14 | -$0.08 | -$3.23 | -$2.38 | -$1.94 | $1.02 | |||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 52.6M | 38.4M | 34.1M | 29.3M | 25.2M | 24.9M | 4.3M | 4.0M | 4.0M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 52.6M | 36.8M | 34.1M | 29.3M | 25.2M | 24.9M | 4.3M | 4.0M | 4.0M | ||||||
| Earnings Per Share Basic | $-0.01 | $0.07 | $-0.06 | $-0.07 | $-0.14 | $-0.08 | $-3.23 | $-2.38 | $-1.94 | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 49.7M | 46.1M | 30.6M | 28.0M | 23.9M | 23.7M | 4.6M | ||||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 30.0M | ||||||||
| Common Stock Shares Issued | 49.9M | 46.3M | 30.8M | 28.2M | 24.1M | 23.9M | 4.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $56.0K | -$9.0K | -$129.0K | -$4.5M | -$6.3M |
| Additional Paid In Capital | $101.9M | $86.1M | $78.0M | $24.0M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.0M | $628.0K | $1.5M | $1.4M | |
| Operating Costs And Expenses | $5.1M | $421.4K | |||
| Stock Issued During Period Value New Issues | $111.0K | $242.0K | $112.0K | $7.5K | $25.0K |
| Realized And Unrealized Gain Loss | $1.4M | $19.1K | |||
| Franchise Tax Expense | $205.6K | $164.0K | |||
| Stock Issued During Period Shares New Issues | 1.9M | 277.8K | 543.1K | ||
| Noncash Interest | $45.0K | $121.0K | $11.0K | ||
| Stock Warrant Expense | $35.0K | $9.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $20.0K | $3.0K | $6.0K | $6.0K | -$7.0K | $113.8K | -$1.6M | -$2.8M | -$1.4M | -$5.0M | |||||||
| Additional Paid In Capital | $97.8M | $97.2M | $87.4M | $85.5M | $78.5M | $78.4M | $22.1M | $1.6M | $2.2M | $0.00 | $0.00 | $0.00 | $692.3K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $142.0K | $197.0K | $208.0K | $207.0K | $103.0K | $137.0K | $798.0K | $280.0K | $368.0K | ||||||||
| Operating Costs And Expenses | $241.1K | $306.3K | $467.2K | $744.5K | $560.2K | $98.7K | $70.5K | $845.00 | |||||||||
| Stock Issued During Period Value New Issues | $111.0K | $242.0K | $25.0K | ||||||||||||||
| Realized And Unrealized Gain Loss | $343.0K | $327.4K | $587.3K | $149.4K | $43.1K | $2.9K | $794.00 | $0.00 | |||||||||
| Franchise Tax Expense | $44.4K | $47.5K | $52.8K | $50.0K | $50.0K | $0.00 | |||||||||||
| Stock Issued During Period Shares New Issues | 288.0K | 216.7K | 245.0K | ||||||||||||||
| Noncash Interest | $25.0K | $38.0K | |||||||||||||||
| Stock Warrant Expense | $33.0K | $2.2M | $1.9M |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.